gms | German Medical Science

Süddeutsche Tage der Kinder- und Jugendmedizin München

04.05. - 06.05.2012, München

Celica disease – Gliadin antibodies as addendum to the guidelines

Meeting Abstract

Search Medline for

  • I. Frank - Medizinisches Versorgungszentrum Bavariahaus, München, Germany
  • S. Razeghi - Praxis für Kinder- und Jugendmedizin, Miesbach, Germany
  • J. Durner - Medizinisches Versorgungszentrum Bavariahaus, München, Germany
  • S. Eber - Praxis für Kinder- und Jugendmedizin, Hämatologie, München, Germany

Süddeutsche Tage der Kinder- und Jugendmedizin. 61. Jahrestagung der Süddeutschen Gesellschaft für Kinder- und Jugendmedizin und der Süddeutschen Gesellschaft für Kinderchirurgie und dem Berufsverband für Kinder- und Jugendärzte – Landesverband Bayern. München, 04.-06.05.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12sgkjP45

DOI: 10.3205/12sgkj85, URN: urn:nbn:de:0183-12sgkj856

Published: April 11, 2012

© 2012 Frank et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

We report about a 1 10/12 year old female toddler, who presented with failure to thrive and increased sweating (pyelonephritis at age of 10 mo). Wheat was introduced since age of 8 mo and weight did not increase since that. Blood was taken to ascertain the suspect of celiac disease.

According to the current guidelines (2010) the transglutaminase IgA antibodies were determined. The level was under the reference interval (< 20 U). In addition the level of gliadin IgG and IgA antibodies as well as F-actin (smooth muscle) IgA antibodies were determined. At that time gliadin IgG antibody titer was at 81.4 U (reference value < 20). This was the first and only laboratory hint of an existing celiac disease. The other celiac disease specific laboratory parameters were negative. Eight month later all celiac disease specific laboratory parameters became positive e.g. transglutaminase Ig A >125.0 U (reference value < 20). Positive F- actin antibodies (>125 U; reference value < 20) indicated villous atrophy. Diagnosis was further ascertained genetically by showing linkage to haplotype HLA DRB1*03 (DR3) and DQB1*02 (DQ2). Upon parental wish we restrained from doing a villous biopsy and started gliadin free nutrition at age of 1 6/12 y, leading to rapid weight gain and stop of clinical complaints. From this case we learned that in addition to the current guidelines the gliadin IgG antibodies can indicate a beginning celiac disease. Therefore it is advisable to add this parameter to the laboratory diagnostic panel because the switch to transglutaminase antibodies takes place a few months later.